View Item 

Show simple item record

Perioperative management of adult living donor liver transplantation: Part 1 – recipients
dc.contributor.authorSakai, Tetsuro
dc.contributor.authorKo, Justin Sangwook
dc.contributor.authorCrouch, Cara E.
dc.contributor.authorKumar, Sathish
dc.contributor.authorLittle, Michael B.
dc.contributor.authorChae, Min Suk
dc.contributor.authorGanoza, Armando
dc.contributor.authorGómez-Salinas, Luis
dc.contributor.authorHumar, Abhi
dc.contributor.authorKim, Sang Hyun
dc.contributor.authorKoo, Bon-Nyeo
dc.contributor.authorRodriguez, Gonzalo
dc.contributor.authorSirianni, Joel
dc.contributor.authorSmith, Natalie K.
dc.contributor.authorSong, Jun-Gol
dc.contributor.authorUllah, Aisha
dc.contributor.authorHendrickse, Adrian
dc.date.accessioned2022-07-05T21:04:22Z
dc.date.available2023-07-05 17:04:20en
dc.date.available2022-07-05T21:04:22Z
dc.date.issued2022-06
dc.identifier.citationSakai, Tetsuro; Ko, Justin Sangwook; Crouch, Cara E.; Kumar, Sathish; Little, Michael B.; Chae, Min Suk; Ganoza, Armando; Gómez-Salinas, Luis ; Humar, Abhi; Kim, Sang Hyun; Koo, Bon-Nyeo ; Rodriguez, Gonzalo; Sirianni, Joel; Smith, Natalie K.; Song, Jun-Gol ; Ullah, Aisha; Hendrickse, Adrian (2022). "Perioperative management of adult living donor liver transplantation: Part 1 - recipients." Clinical Transplantation 36(6): n/a-n/a.
dc.identifier.issn0902-0063
dc.identifier.issn1399-0012
dc.identifier.urihttps://hdl.handle.net/2027.42/173035
dc.description.abstractLiving donor liver transplantation was first developed to mitigate the limited access to deceased donor organs in Asia in the 1990s. This alternative liver transplantation option has become an established and widely practiced transplantation method for adult patients suffering from end-stage liver disease. It has successfully addressed the shortage of deceased donors. The Society for the Advancement of Transplant Anesthesia and the Korean Society of Transplant Anesthesia jointly reviewed published studies on the perioperative management of live donor liver transplant recipients. The review aims to offer transplant anesthesiologists and critical care physicians a comprehensive overview of the perioperative management of adult live liver transplantation recipients. We feature the status, outcomes, surgical procedure, portal venous decompression, anesthetic management, prevention of acute kidney injury, avoidance of blood transfusion, monitoring and therapeutic strategies of hemodynamic derangements, and Enhanced Recovery After Surgery protocols for liver transplant recipients.
dc.publisherWiley Periodicals, Inc.
dc.subject.otheranesthesia
dc.subject.otherKSTA
dc.subject.otherliver transplantation
dc.subject.otherliving donor liver transplantation
dc.subject.otherrecipients
dc.subject.otherreview
dc.subject.otherSATA
dc.titlePerioperative management of adult living donor liver transplantation: Part 1 – recipients
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMedicine (General)
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173035/1/ctr14667_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/173035/2/ctr14667.pdf
dc.identifier.doi10.1111/ctr.14667
dc.identifier.sourceClinical Transplantation
dc.identifier.citedreferenceMandell D, Planinsic R, Melean F, et al. Critical importance of low-dose tissue plasminogen activator policy for treating intraoperative pulmonary thromboembolism during liver transplantation. Semin Cardiothorac Vasc Anesth. 2018; 22 ( 4 ): 376 – 382.
dc.identifier.citedreferenceWang JY, Mackensen GB, Vitin A, Martay K. Role of transesophageal echocardiography in the diagnosis of multi-chamber intracardiac thrombosis during liver transplantation: a case series. J Crit Care Med. 2020; 6 ( 3 ): 194 – 199.
dc.identifier.citedreferenceYuasa T, Niwa N, Kimura S, et al. Intraoperative blood loss during living donor liver transplantation: an analysis of 635 recipients at a single center. Transfusion. 2005; 45 ( 6 ): 879 – 884.
dc.identifier.citedreferenceOlthoff KM, Smith AR, Abecassis M, et al. Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg. 2015; 262 ( 3 ): 465 – 475.
dc.identifier.citedreferenceFrasco PE, Poterack KA, Hentz JG, Mulligan DC. A comparison of transfusion requirements between living donation and cadaveric donation liver transplantation: relationship to model of end-stage liver disease score and baseline coagulation status. Anesth Analg. 2005; 101 ( 1 ): 30 – 37.
dc.identifier.citedreferenceTsai HW, Hsieh FC, Chang CC, et al. Clinical practice of blood transfusion in orthotopic organ transplantation: a single institution experience. Asian Pac J Cancer Prev. 2015; 16 ( 17 ): 8009 – 8013.
dc.identifier.citedreferenceDanforth D, Gabriel RA, Clark AI, et al. Preoperative risk factors for massive transfusion, prolonged ventilation requirements, and mortality in patients undergoing liver transplantation. Korean J Anesthesiol. 2020; 73 ( 1 ): 30 – 35.
dc.identifier.citedreferenceMassicotte L, Lenis S, Thibeault L, Sassine MP, Seal RF, Roy A. Effect of low central venous pressure and phlebotomy on blood product transfusion requirements during liver transplantations. Liver Transpl. 2006; 12 ( 1 ): 117 – 123.
dc.identifier.citedreferenceArshad F, Lisman T, Porte RJ. Blood markers of portal hypertension are associated with blood loss and transfusion requirements during orthotopic liver transplantation. Semin Thromb Hemost. 2020; 46 ( 6 ): 751 – 756.
dc.identifier.citedreferenceHan S, Kim G, Ko JS, et al. Safety of the use of blood salvage and autotransfusion during liver transplantation for hepatocellular carcinoma. Ann Surg. 2016; 264 ( 2 ): 339 – 343.
dc.identifier.citedreferenceKwon JH, Han S, Kim D, et al. blood salvage and autotransfusion does not increase the risk of tumor recurrence after liver transplantation for advanced hepatocellular carcinoma. Ann Surg. 2021; Mar 18. https://doi.org/10.1097/SLA.0000000000004866
dc.identifier.citedreferenceKamel Y, Hassanin A, Ahmed AR, et al. Perioperative thromboelastometry for adult living donor liver transplant recipients with a tendency to hypercoagulability: a prospective observational cohort study. Transfus Med Hemother. 2018; 45 ( 6 ): 404 – 412.
dc.identifier.citedreferenceBonnet A, Gilquin N, Steer N, et al. The use of a thromboelastometry-based algorithm reduces the need for blood product transfusion during orthotopic liver transplantation: a randomised controlled study. Eur J Anaesthesiol. 2019; 36 ( 11 ): 825 – 833.
dc.identifier.citedreferenceCrouch C, Sakai T, Aniskevich S, et al. Adult liver transplant anesthesiology practice patterns and resource utilization in the United States: survey results from the society for the advancement of transplant anesthesia. Clin Transplant. 2021; 36: e14504.
dc.identifier.citedreferenceKutzler HL, Gannon R, Nolan W, et al. Opioid avoidance in liver transplant recipients: reduction in postoperative opioid use through a multidisciplinary multimodal approach. Liver Transpl. 2020; 26 ( 10 ): 1254 – 1262.
dc.identifier.citedreferenceHausken J, Haugaa H, Hagness M, Line PD, Melum E, Tønnessen TI. Thoracic epidural analgesia for postoperative pain management in liver transplantation: a 10-year study on 685 liver transplant recipients. Transplant Direct. 2021; 7 ( 2 ): e648.
dc.identifier.citedreferenceTong K, Nolan W, O’Sullivan DM, Sheiner P, Kutzler HL. Implementation of a multimodal pain management order set reduces perioperative opioid use after liver transplantation. Pharmacotherapy. 2019; 39 ( 10 ): 975 – 982.
dc.identifier.citedreferenceFukazawa K, Rodriguez PJ, Fong CT, Gologorsky E. Perioperative opioid use and chronic post-surgical pain after liver transplantation: a single center observational study. J Cardiothorac Vasc Anesth. 2020; 34 ( 7 ): 1815 – 1821.
dc.identifier.citedreferenceRodríguez-Laiz GP, Melgar-Requena P, Alcázar-López CF, et al. Fast-track liver transplantation: six-year prospective cohort study with an enhanced recovery after surgery (ERAS) protocol. World J Surg. 2021; 45 ( 5 ): 1262 – 1271.
dc.identifier.citedreferenceKheterpal S, Vaughn MT, Dubovoy TZ, et al. Sugammadex versus neostigmine for reversal of neuromuscular blockade and postoperative pulmonary complications (STRONGER): a multicenter matched cohort analysis. Anesthesiology. 2020; 132 ( 6 ): 1371 – 1381.
dc.identifier.citedreferenceMandell MS, Stoner TJ, Barnett R, et al. A multicenter evaluation of safety of early extubation in liver transplant recipients. Liver Transpl. 2007; 13 ( 11 ): 1557 – 1563.
dc.identifier.citedreferenceGlanemann M, Busch T, Neuhaus P, Kaisers U. Fast tracking in liver transplantation. Immediate postoperative tracheal extubation: feasibility and clinical impact. Swiss Med Wkly. 2007; 137 ( 13-14 ): 187 – 191.
dc.identifier.citedreferencePlevak DJ, Torsher LC. Fast tracking in liver transplantation. Liver Transpl Surg. 1997; 3 ( 4 ): 447 – 448.
dc.identifier.citedreferenceFindlay JY, Jankowski CJ, Vasdev GM, et al. Fast track anesthesia for liver transplantation reduces postoperative ventilation time but not intensive care unit stay. Liver Transpl. 2002; 8 ( 8 ): 670 – 675.
dc.identifier.citedreferenceTaner CB, Willingham DL, Bulatao IG, et al. Is a mandatory intensive care unit stay needed after liver transplantation? Feasibility of fast-tracking to the surgical ward after liver transplantation. Liver Transpl. 2012; 18 ( 3 ): 361 – 369.
dc.identifier.citedreferenceLoh C-PA, Croome KP, Taner CB, Keaveny AP. Bias-corrected estimates of reduction of post-surgery length of stay and corresponding cost savings through the widespread national implementation of fast-tracking after liver transplantation: a quasi-experimental study. J Med Econ. 2019; 22 ( 7 ): 684 – 690.
dc.identifier.citedreferenceAdachi T, Murakawa M, Uetsuki N, Segawa H. Living related donor liver transplantation in a patient with severe aortic stenosis. Br J Anaesth. 1999; 83 ( 3 ): 488 – 490.
dc.identifier.citedreferenceJuneja R, Kumar A, Ranjan R, et al. Combined off pump coronary artery bypass graft and liver transplant. Ann Card Anaesth. 2021; 24 ( 2 ): 197 – 202.
dc.identifier.citedreferenceKaliamoorthy I, Rajakumar A, Varghese J, George S, Rela M. Living donor liver transplantation following transcatheter aortic valve implantation for aortic valvular disease. Semin Cardiothorac Vasc Anesth. 2020; 24 ( 3 ): 273 – 278.
dc.identifier.citedreferenceAbougergi MS, Rai R, Cohen CK, Montgomery R, Solga SF. Trends in adult-to-adult living donor liver transplant organ donation: the Johns Hopkins experience. Prog Transplant. 2006; 16 ( 1 ): 28 – 32.
dc.identifier.citedreferenceMellinger JL. Living donor liver transplant in alcohol-related liver disease: an option whose time has come. Transplantation. 2020; 104 ( 2 ): 235 – 236.
dc.identifier.citedreferenceBraun HJ, Dodge JL, Grab JD, et al. Living donor liver transplant for alcoholic liver disease: data from the adult-to-adult living donor liver transplantation study. Transplantation. 2020; 104 ( 2 ): 285 – 292.
dc.identifier.citedreferenceEguchi S, Yanaga K, Fujita F, et al. Living-related right lobe liver transplantation for a patient with fulminant hepatic failure during the second trimester of pregnancy: report of a case. Transplantation. 2002; 73 ( 12 ): 1970 – 1971.
dc.identifier.citedreferenceMatsui Y, Sugawara Y, Yamashiki N, et al. Living donor liver transplantation for fulminant hepatic failure. Hepatol Res. 2008; 38 ( 10 ): 987 – 996.
dc.identifier.citedreferenceAl Sebayel M, Abaalkhail F, Hashim A, et al. Living donor liver transplant versus cadaveric liver transplant survival in relation to model for end-stage liver disease score. Transplant Proc. 2015; 47 ( 4 ): 1211 – 1213.
dc.identifier.citedreferenceGrant D, Fisher RA, Abecassis M, McCaughan G, Wright L, Fan ST. Fan. Liver Transpl. 2011; 17 Suppl 2: S133 – S138.
dc.identifier.citedreferencePark MS, Lee KW, Suh SW, et al. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Transplantation. 2014; 97 ( 1 ): 71 – 77.
dc.identifier.citedreferenceLiang W, Wu L, Ling X, et al. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl. 2012. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl; 18 ( 10 ): 1226 – 1236.
dc.identifier.citedreferenceNinomiya M, Shirabe K, Facciuto ME, et al. Comparative study of living and deceased donor liver transplantation as a treatment for hepatocellular carcinoma. J Am Coll Surg. 2015; 220 ( 3 ): 297 – 304.
dc.identifier.citedreferenceHumar A, Ganesh S, Jorgensen D, et al. Adult living donor versus deceased donor liver transplant (LDLT versus DDLT) at a single center: time to change our paradigm for liver transplant. Ann Surg. 2019; 270: 444 – 451.
dc.identifier.citedreferenceKwong AJ, Kim WR, Lake JR, et al. OPTN/SRTR 2019 annual data report: liver. Am J Transplant. 2021; 21 Suppl 2: 208 – 315.
dc.identifier.citedreferenceBerg CL, Gillespie BW, Merion RM, et al, A2ALL Study Group. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology. 2007; 133 ( 6 ): 1806 – 1813.
dc.identifier.citedreferenceTrotter JF, Wachs M, Everson GT, Kam I. Adult-to-adult transplantation of the right hepatic lobe from a living donor. New Engl J Med. 2002; 346: 1074 – 1081.
dc.identifier.citedreferenceFreise CE, Gillespie BW, Koffron AJ, et al, Everhart JE and the A2ALL Study Group. Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL retrospective cohort study. Am J Transplant. 2008; 8: 2569 – 2579.
dc.identifier.citedreferenceBusani S, Marconi G, Schiavon L, et al. Living donor liver transplantation and management of portal venous pressure. Transplant Proc. 2006; 38 ( 4 ): 1074 – 1075.
dc.identifier.citedreferenceTaner CB, Dayangac M, Akin B. Donor safety and remnant liver volume in living donor liver transplantation. Liver Transplant. 2008; 14: 1174 – 1179.
dc.identifier.citedreferenceFeng Y, Han Z, Wang X, Chen H, Li Y. Association of graft-to-recipient weight ratio with the prognosis following liver transplantation: a meta-analysis. J Gastrointest Surg. 2020; 24 ( 8 ): 1869 – 1879.
dc.identifier.citedreferenceSchroeder T, Nadalin S, Stattaus J, Debatin JF, Malagó M, Ruehm SG. Potential living liver donors: evaluation with an all-in-one protocol with multi-detector row CT. Radiology. 2002; 224: 586 – 591.
dc.identifier.citedreferenceFulcher AS, Szucs RA, Bassignani MJ, Marcos A. Right lobe living donor liver transplantation: preoperative evaluation of the donor with MR imaging. AJR Am J Roentgenol. 2001; 176: 1483 – 1491.
dc.identifier.citedreferenceMohapatra N, Gurumoorthy Subramanya Bharathy K, Kumar Sinha P, Vasantrao Sasturkar S, Patidar Y, Pamecha V. Three-dimensional volumetric assessment of graft volume in living donor liver transplantation: does it minimise errors of estimation?. J Clin Exp Hepatol. 2020; 10 ( 1 ): 1 – 8.
dc.identifier.citedreferenceTulla KA, Jeon H. Living donor liver transplantation: technical innovations. Gastroenterol Clin North Am. 2018; 47 ( 2 ): 253 – 265.
dc.identifier.citedreferenceLee SG. A complete treatment of adult living donor liver transplantation: a review of surgical technique and current challenges to expand indication of patients. Am J Transplant. 2015; 15 ( 1 ): 17 – 38.
dc.identifier.citedreferenceSeehofer D, Eurich D, Veltzke-Schlieker W, Neuhaus P. Biliary complications after liver transplantation: old problems and new challenges. Am J Transplant. 2013; 13 ( 2 ): 253 – 265.
dc.identifier.citedreferenceMukhtar A, Dabbous H. Modulation of splanchnic circulation: role in perioperative management of liver transplant patients. World J Gastroenterol. 2016; 22 ( 4 ): 1582 – 1592.
dc.identifier.citedreferenceByram SW, Gupta RA, Ander M, Edelstein S, Andreatta B. Effects of continuous octreotide infusion on intraoperative transfusion requirements during orthotopic liver transplantation. Transplant Proceed. 2015; 47: 2712 – 2714.
dc.identifier.citedreferenceEscorsell A, Bandi JC, Andreu V, et al. Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology. 2001; 120 ( 1 ): 161 – 169.
dc.identifier.citedreferenceSahmeddini MA, Amini A, Naderi N. The effect of octreotide on urine output during orthotopic liver transplantation and early postoperative renal function; A randomized, double-blind, placebo controlled trial. Hepat Mon. 2013; 13 ( 9 ): e12787.
dc.identifier.citedreferenceWagener G, Gubitosa G, Renz J, et al. Vasopressin decreases portal vein pressure and flow in the native liver during liver transplantation. Liver Transpl. 2008; 14 ( 11 ): 1664 – 1670.
dc.identifier.citedreferenceMukhtar A, Salah M, Aboulfetouh F, et al. The use of terlipressin during living donor liver transplantation: effects on systemic and splanchnic hemodynamics and renal function. Crit Care Med. 2011; 39 ( 6 ): 1329 – 1334.
dc.identifier.citedreferenceKaraaslan P, Sevmis S. Effect of terlipressin infusion therapy on recipient’s hepatic and renal functions in living donor liver transplantations: experience from a tertiary hospital. Nigerian J Clin Pract. 2019; 22 ( 2 ): 265 – 269.
dc.identifier.citedreferenceWon YJ, Kim HJ, Lim BG, Ahn HS, Hwang MH, Lee IO. Effect of perioperative terlipressin on postoperative renal function in patients who have undergone living donor liver transplantation: a meta-analysis of randomized controlled trials. Transplant Proc. 2015; 47: 1917 – 1925.
dc.identifier.citedreferenceReddy MS, Kaliamoorthy I, Rajakumar A, et al. Double-blind randomized controlled trial of the routine perioperative use of terlipressin in adult living donor liver transplantation. Liver Transpl. 2017; 23 ( 8 ): 1007 – 1014.
dc.identifier.citedreferenceSakai T, Gligor S, Diulus J, McAffee R, Marsh JW, Planinsic RM. Insertion and management of percutaneous veno-venous bypass cannula for liver transplantation: a reference for transplant anesthesiologists. Clin Transplant. 2010; 24: 585 – 591.
dc.identifier.citedreferenceBarnett R. Pro: veno-veno bypass should routinely be used during liver transplantation. J Cardiothorac Vasc Anesth. 2006; 20 ( 5 ): 742 – 743.
dc.identifier.citedreferenceSun K, Hong F, Wang Y, et al. Venovenous bypass is associated with a lower incidence of acute kidney injury after liver transplantation in patients with compromised pretransplant renal function. Anesth Analg. 2017; 125 ( 5 ): 1463 – 1470.
dc.identifier.citedreferenceHilmi IA, Planinsic RM. Con: venovenous bypass should not be used in orthotopic liver transplantation. J Cardiothorac Vasc Anesth. 2006; 20 ( 5 ): 744 – 747.
dc.identifier.citedreferenceSakai T, Matsusaki T, Marsh JW, Hilmi IA, Planinsic RM. Comparison of surgical methods in liver transplantation: retrohepatic caval resection with venovenous bypass (VVB) versus piggyback (PB) with VVB versus PB without VVB. Transpl Int. 2010; 23: 1247 – 1248.
dc.identifier.citedreferenceSakai T, Planinsic RM, Hilmi IA, Marsh JW. Complications associated with percutaneous placement of venous return cannula for venovenous bypass in adult orthotopic liver transplantation. Liver Trans. 2007; 13: 961 – 965.
dc.identifier.citedreferenceSamstein B, Smith AR, Freise CE, et al. Complications and their resolution in recipients of deceased and living donor liver transplants: findings from the A2ALL cohort study. Am J Transplant. 2016; 16: 594 – 602.
dc.identifier.citedreferenceAddeo P, Locicero A, Faitot F, Bachellier P. Temporary right portocaval shunt during piggyback liver transplantation. World J Surg. 2019; 43: 2612 – 2615.
dc.identifier.citedreferenceNacif LS, Zanini LY, Sartori VF, et al. Intraoperative surgical portosystemic shunt in liver transplantation: systematic review and meta-analysis. Ann Transplant. 2018; 23: 721 – 732.
dc.identifier.citedreferenceFaitot F, Addeo P, Besch C, et al. Passive mesenterico-saphenous shunt: an alternative to portocaval anastomosis for tailored portal decompression during liver transplantation. Surgery. 2019; 165 ( 5 ): 970 – 977.
dc.identifier.citedreferencePomposelli JJ. hepatic artery thrombosis after liver transplant: not a surgical problem?. Transplantation. 2016; 100 ( 11 ): 2251.
dc.identifier.citedreferencePomposelli JJ, Goodrich NP, Emond JC, et al. Patterns of early allograft dysfunction in adult live donor liver transplantation: the A2ALL experience. Transplantation. 2016; 100 ( 7 ): 1490 – 1499.
dc.identifier.citedreferenceO’Riordan J, O’Beirne HA, Young Y, Bellamy MC. Effects of desflurane and isoflurane on splanchnic microcirculation during major surgery. Br J Anaesth. 1997; 78 ( 1 ): 95 – 96.
dc.identifier.citedreferenceKo JS, Gwak MS, Choi SJ, et al. The effects of desflurane and sevoflurane on hepatic and renal functions after right hepatectomy in living donors. Transpl Int. 2010; 23 ( 7 ): 736 – 744.
dc.identifier.citedreferenceKo JS, Gwak MS, Choi SJ, et al. The effects of desflurane and propofol-remifentanil on postoperative hepatic and renal functions after right hepatectomy in liver donors. Liver Transpl. 2008; 14 ( 8 ): 1150 – 1158.
dc.identifier.citedreferenceHartman JC, Pagel PS, Proctor LT, Kampine JP, Schmeling WT, Warltier DC. Influence of desflurane, isoflurane and halothane on regional tissue perfusion in dogs. Can J Anaesth. 1992; 39 ( 8 ): 877 – 887.
dc.identifier.citedreferenceGelman S. General anesthesia and hepatic circulation. Can J Physiol Pharmacol. 1987; 65 ( 8 ): 1762 – 1779.
dc.identifier.citedreferenceGrundmann U, Zissis A, Bauer C, Bauer M. In vivo effects of halothane, enflurane, and isoflurane on hepatic sinusoidal microcirculation. Acta Anaesthesiol Scand. 1997; 41 ( 6 ): 760 – 765.
dc.identifier.citedreferenceMerin RG, Bernard JM, Doursout MF, Cohen M, Chelly JE. Comparison of the effects of isoflurane and desflurane on cardiovascular dynamics and regional blood flow in the chronically instrumented dog. Anesthesiology. 1991; 74 ( 3 ): 568 – 574.
dc.identifier.citedreferenceZaleski L, Abello D, Gold MI. Desflurane versus isoflurane in patients with chronic hepatic and renal disease. Anesth Analg. 1993; 76 ( 2 ): 353 – 356.
dc.identifier.citedreferenceFrink EJ Jr, Morgan SE, Coetzee A, Conzen PF. The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology. 1992; 76 ( 1 ): 85 – 90.
dc.identifier.citedreferenceTsai YF, Lin CC, Lee WC, Yu HP. Propofol attenuates ischemic reperfusion-induced formation of lipid peroxides in liver transplant recipients. Transplant Proc. 2012; 44 ( 2 ): 376 – 379.
dc.identifier.citedreferenceYe L, Luo CZ, McCluskey SA, Pang QY, Zhu T. Propofol attenuates hepatic ischemia/reperfusion injury in an in vivo rabbit model. J Surg Res. 2012; 178 ( 2 ): e65 – e70.
dc.identifier.citedreferenceWu ZF, Lin WL, Lee MS, et al. Propofol vs desflurane on the cytokine, matrix metalloproteinase-9, and heme oxygenase-1 response during living donor liver transplantation: a pilot study. Medicine (Baltimore). 2019; 98 ( 48 ): e18244.
dc.identifier.citedreferenceShin S, Joo DJ, Kim MS, et al. Propofol intravenous anaesthesia with desflurane compared with desflurane alone on postoperative liver function after living-donor liver transplantation: a randomised controlled trial. Eur J Anaesthesiol. 2019; 36 ( 9 ): 656 – 666.
dc.identifier.citedreferenceLee S. Dexmedetomidine: present and future directions. Korean J Anesthesiol. 2019; 72 ( 4 ): 323 – 330.
dc.identifier.citedreferenceDamian MA, Hammer GB, Elkomy MH, Frymoyer A, Drover DR, Su F. Pharmacokinetics of dexmedetomidine in infants and children after orthotopic liver transplantation. Anesth Analg. 2020; 130 ( 1 ): 209 – 216.
dc.identifier.citedreferenceDai WB, Chen LK, Qi SY, et al. Lactated Ringer’s solution versus normal saline in pediatric living-donor liver transplantation: a matched retrospective cohort study. Paediatr Anaesth. 2021; 31 ( 6 ): 702 – 712.
dc.identifier.citedreferenceShin W, Kim Y, Bang J, Cho S, SM H, Hwang G. Lactate and liver function tests after living donor right hepatectomy: a comparison of solutions with and without lactate. Acta Anaesthesiol Scand. 2011; 55 ( 5 ): 558 – 564.
dc.identifier.citedreferenceAttalla H, Abulkassem M, Elenine K. Assessment of intraoperative use of Ringer acetate in patients with liver cirrhosis. Alexandria J Anaesth Intensive Care. 2005; 270 ( 1 ): 75 – 82.
dc.identifier.citedreferenceMukhtar A, Aboulfetouh F, Obayah G, et al. The safety of modern hydroxyethyl starch in living donor liver transplantation: a comparison with human albumin. Anesth Analg. 2009; 109 ( 3 ): 924 – 930.
dc.identifier.citedreferenceDemir A, Aydınlı B, Toprak HI, et al. Impact of 6% starch 130/0.4 and 4% gelatin infusion on kidney function in living-donor liver transplantation. Transplant Proc; 47 ( 6 ): 1883 – 1889.
dc.identifier.citedreferenceMizota T, Minamisawa S, Imanaka Y, Fukuda K. Oliguria without serum creatinine increase after living donor liver transplantation is associated with adverse postoperative outcomes. Acta Anaesthesiol Scand. 2016; 60: 874 – 881.
dc.identifier.citedreferenceKim WH, Lee HC, Lim L, Ryu HG, Jung CW. Intraoperative oliguria with decreased SvO(2) predicts acute kidney injury after living donor liver transplantation. J Clin Med. 2019; 8: 29.
dc.identifier.citedreferenceJun IG, Lee B, Kim SO, et al. Comparison of acute kidney injury between ABO-compatible and ABO-incompatible living donor liver transplantation: a propensity matching analysis. Liver Transpl. 2016; 22 ( 12 ): 1656 – 1665.
dc.identifier.citedreferenceThongprayoon C, Kaewput W, Thamcharoen N, et al. Incidence and impact of acute kidney injury after liver transplantation: a meta-analysis. J Clin Med. 2019; 8 ( 3 ): 372.
dc.identifier.citedreferenceDurand F, Francoz C, Asrani SK, et al. Acute kidney injury after liver transplantation. Transplantation. 2018; 102 ( 10 ): 1636 – 1649.
dc.identifier.citedreferencePark MH, Shim HS, Kim WH, et al. Clinical risk scoring models for prediction of acute kidney injury after living donor liver transplantation: a retrospective observational study. PLoS One. 2015; 10 ( 8 ): e0136230.
dc.identifier.citedreferenceZhou J, Zhang X, Lyu L, Ma X, Miao G, Chu H. Modifiable risk factors of acute kidney injury after liver transplantation: a systematic review and meta-analysis. BMC Nephrol. 2021; 22: 149.
dc.identifier.citedreferenceKandil MA, Abouelenain KM, Alsebaey A, et al. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: a randomized controlled trial. Clin Transplant. 2017; 31 ( 8 ): e13019.
dc.identifier.citedreferenceTaneja S, Chawla YK. Perioperative use of terlipressin in adult liver transplant. Liver Transpl. 2017; 23: 995 – 996.
dc.identifier.citedreferenceAggarwal S, Kang Y, Freeman A, Fortunato FL, Pinsky M. Postreperfusion syndrome: hypotension after reperfusion of the transplanted liver. J Crit Care. 1993; 8 ( 3 ): 154 – 160.
dc.identifier.citedreferenceYassen AM, Elsarraf WR, Elmorshedi MA, et al. Short-term effects of extracorporeal graft rinse versus circulatory graft rinse in living donor liver transplantation. A prospective randomized controlled trial. Transpl Int. 2017; 30 ( 7 ): 725 – 733.
dc.identifier.citedreferenceChung IS, Kim HY, Shin YH, et al. Incidence and predictors of post-reperfusion syndrome in living donor liver transplantation. Clin Transplant. 2012; 26 ( 4 ): 539 – 543.
dc.identifier.citedreferenceVoigt M, Delario G. Perspectives on abdominal organ preservation solutions: a comparative literature review. Prog Transplant. 2013; 23 ( 4 ): 383 – 391.
dc.identifier.citedreferenceTesta G, Malagó M, Nadalin S, et al. Histidine-tryptophan-ketoglutarate versus University of Wisconsin solution in living donor liver transplantation: results of a prospective study. Liver Transpl. 2003; 9 ( 8 ): 822 – 826.
dc.identifier.citedreferenceChan SC, Liu CL, Lo CM, Fan ST. Applicability of histidine-tryptophan-ketoglutarate solution in right lobe adult-to-adult live donor liver transplantation. Liver Transplant. 2004; 10 ( 11 ): 1415 – 1421.
dc.identifier.citedreferenceXu X, Zhu YF, Lv T, et al. Histidine-tryptophan-ketoglutarate solution versus University of Wisconsin solution in adult-to-adult living donor liver transplantation: a propensity score matching analysis from mainland China. Medicine (Baltimore). 2020; 99 ( 51 ): e23584.
dc.identifier.citedreferenceKo JS, Kim GS, Gwak MS, et al. Greater hemodynamic instability with histidine-tryptophan-ketoglutarate solution than university of wisconsin solution during the reperfusion period in living donor liver transplantation. Transplant Proc. 2008; 40: 3308 – 3310.
dc.identifier.citedreferenceDe Vroege R, Wildevuur WR, Muradin JAG, Graves D, Van Oeveren W. Washing of stored red blood cells by an autotransfusion device before transfusion. Vox Sang. 2007; 92 ( 2 ): 130 – 135.
dc.identifier.citedreferenceKnichwitz G, Zahl M, Van Aken H, Semjonow A, Booke M. Intraoperative washing of long-stored packed red blood cells by using an autotransfusion device prevents hyperkalemia. Anesth Analg. 2002; 95 ( 2 ): 324 – 325.
dc.identifier.citedreferenceChung IS, Jee HS, Han S, et al. Effect of prereperfusion ephedrine on postreperfusion syndrome and graft function in living donor liver transplantation. Transplant Proc. 2017; 49: 1815.
dc.identifier.citedreferenceLee SH, Gwak MS, Choi SJ, et al. Intra-operative cardiac arrests during liver transplantation - a retrospective review of the first 15 yr in Asian population. Clin Transplant. 2013; 27 ( 2 ): E126 – E136.
dc.identifier.citedreferenceSmith NK, Zerillo J, Kim SJ, et al. Intraoperative cardiac arrest during adult liver transplantation: incidence and risk factor analysis from 7 academic centers in the United States. Anesth Analg. 2021; 132 ( 1 ): 130 – 139.
dc.identifier.citedreferenceMatsusaki T, Hilmi IA, Planinsic RM, Humar A, Sakai T. Cardiac arrest during adult liver transplantation: a single institution’s experience with 1238 deceased donor transplants. Liver Transplant. 2013; 19: 1262 – 1271.
dc.identifier.citedreferenceSakai T, Matsusaki T, Dai F, et al. Pulmonary thromboembolism during adult liver transplantation: incidence, clinical presentation, outcome, risk factors, and diagnostic predictors. Br J Anaesth. 2012; 108 ( 3 ): 469 – 477.
dc.identifier.citedreferenceNicolau-Raducu R, Beduschi T, Vianna R, et al. Fibrinolysis shutdown is associated with thrombotic and hemorrhagic complications and poorer outcomes after liver transplantation. Liver Transpl. 2019; 25 ( 3 ): 380 – 387.
dc.identifier.citedreferenceGologorsky E, De Wolf AM, Scott V, Aggarwal S. Intracardiac thrombus formation and pulmonary thromboembolism immediately after graft reperfusion in 7 patients undergoing liver transplantation. Liver Transpl. 2001; 7 ( 9 ): 783 – 789.
dc.identifier.citedreferencePeiris P, Pai SL. Intracardiac thrombosis during liver transplant: a 17-year single-institution study. Liver Transpl. 2015; 21 ( 10 ): 1280 – 1285.
dc.identifier.citedreferenceDe Marchi L, Wang CJ, Skubas NJ, et al. Safety and benefit of transesophageal echocardiography in liver transplant surgery: a position paper from the society for the advancement of transplant anesthesia (SATA). Liver Transpl. 2020; 26 ( 8 ): 1019 – 1029.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
ctr14667_am.pdf
Size:
1.743MB
Format:
PDF
View/Open
Name:
ctr14667.pdf
Size:
948.9KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.